Arner and Eriksson, “Mammalian Deoxyribonicleoside Kinases,” Pharm. Ther., 1995, 67(2), 155-186. |
Berk et al., “A Genetically Distinct Tymidine Kinase in Mammalian Mitochondria,” J Biol Chem, 1973, 248, 2722-2729. |
Bestwick et al., “Selective Expansion of Mitochondrial Nucleoside Triphosphate Pools in Antimetabolite-treated HeLa Cells,” J Biol Chem, 1982, 257, 9300-9304. |
Bridges et al., “Characterization of a dCTP Transport Activity Reconstituted from Human Mitochondria,” J. Biol. Chem, Feb. 19, 1999, 274(8), 4620-4625. |
Bridges et al., “Identification of a novel mitochondrial dNTP carrier and its interaction with anti-HIV nucleoside analogs,” Proc. Am. Assoc. Cancer Res., Mar. 1997, 38, 141. |
Bridges et al., “Inhibition of Mammalian DNA Polymerase-Associated 3' to 5' Exonuclease Activity by 5'-Monophosphates of 3'-Azido-3'-Deoxythymine and 3'-Amino-3'-Deoxythymidine,” Biochemical Pharmacology, 1993, 45(8), 1571-1576. |
Chariot et al., “Zidovudine-induced mitochondrial disorder with massive liver steatosis myopathy, lactic acidosis, and mitochondrial DNA depletion,” J. Hepatology, 1990, 30, 156-160. |
Chang et al., “Biochemical Pharmacology of (+)- and (−)-2',3'-Dideoxy-3'-thiacytidine as Antihepatitis B Virus Agents,” J Biol Chem, Nov. 5, 1992, 267(31), 22414-22420. |
Chen et al., “Delayed Cytotoxicity and Selective Loss of Mitochondrial DNA in Cells Treated with the Anti-human Immunodeficiency Virus Compound 2',3'-Dideoxycytudine,” J Biol Chem, 1989, 264, 11934-11937. |
Chen et al., “The Role of Cytoplasmic Deoxycytidine Kinase in the Mitochondrial Effects of the Anti-human Immunodeficiency Virus Compound 2',3'-Dideoxycytidine,” J Biol Chem, Feb. 15, 1992, 267(5), 2856-2859. |
Cui et al., “Effect of Nucleoside Analogs on Neurite Regeneration and Mitochondrial DNA Synthesis in PC-12 Cells,” J. of Pharmacology and Experimental Therapeutics, 1997, 280(3), 1228-1234. |
Davis et al., “In Situ Localization of Mitochondrial DNA Replication in Intact Mammalian Cells,” J. Cell Biol, 1996, 135, 883-893. |
Doong et al., “Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues,” Proc. Natl. Acad. Sci., Oct. 1991, 88, 8495-8499. |
Dutschman et al., “Metabolism of 2',3'-dideoxy-2',3'didehydro-β-L-(−)-5-Fluorocytidine and Its Activity in Combination with Clinically Approved Anti-Humna Immunodeficiency Virus β-D-(+) Nucleoside Analogs In Vitro,” Antimicrobial Agents and Chemotherapy, Jul. 1998, 42(7), 1799-1804. |
Hernandez-Santiago et al., “Pharmacology of β-L-Thymidine and β-L-2'-eoxycytidine in HepG2 Cell and Primary Human Hepatocytes: Relevance to Chemotherapeutic Efficacy against Hepatitis B Virus,” Antimicrobial Agents and Chemotherapy, Jun. 2002, 46(6), 1728-1733. |
Jurovcik and Holy “Metabolism of pyrimidine L-nucleosides,” Nucleic Acids Research, Aug. 1976, 3(8), 2143-2153. |
Krayevsky and Chernov, “Can a Substrate Enantiomer Be a Substrate for the Same Enzyme?,” Molecular Biology, 1996, 30(5), 585-591. |
Krayevsky and Chernov, “Should the Asymmetric of Enzymatic Active Centers Always Correlate with the Asymmetry of their Substrates?,” J. of Bionolecular Structure & Dynamics, 1996, 14(2), 225-230. |
Labenz et al., “Analysis of the TK Enzyme Complex Induced by HSV Types 1 and 2 by Means of Isoelectric Focusing and Polyacyrlamide Gel Electrophoresis,” Arch Virol, 1982, 71, 235-249. |
Lin et al., “Synthesis and Biological Evaluation of 2'-3'-Dideoxy-L-pyrimidine Nucleosides as Potential Antiviral Agents agains HIV and HBV,” J. Med. Chem, 1994, 97, 798-803. |
Pan-Zhou et al., “Differential Effects of Antiretroviral Nucleoside Analogs on Mitochordrial Function in HepG2 Cells,” Antimicrobial Agents and Chemotherapy, Mar. 2000, 44(3), 496-503. |
Placidi et al., “Cellular pharmacology of β-L-thymidine and β-L-2'-deoxycytidine in HepG2 cells and primary rat, monkey and human hepatocytes,” 3rd Int. Conf. Ther. Vir. Hepatitis, abstr. A122, 1999 [Antivir. Ther. 4, Suppl. 4]. |
Soderlund and Arner, “Mitochondrial versus Cytosolic Activities of Deoxyribonucleoside Salvage Enzymes,” Purine and Pyrimidine Metabolism in Man VIII, A.Shota & M. Taylor (ed.), Plenum Press, New York, 1995, 201-204. |
Zhu et al., “Anti-Hepatitis B Virus Activity and Metabolism of 2',3'-dideoxy-2',3'-didehydro-β-L-(+)-5-Fluorocytidine,” Antimicrobial Agents and Chemotherapy, Jul. 1998, 42(7), 1805-1810. |
Zhu et al., “Incorporation of Nucleoside Analogs into Nuclear or Mitochondrial DNA Is Determined by the Intracellular Phosphorylation Site,” J Biol Chem, 2000, 275(35), 26727-26731. |
Zhu et al., “Inhibition of Replication of Hepatitis B Virus by Cytallene In Vitro,” Antimicrobial Agents and Chemotherapy, Aug. 1997, 41(8), 1755-1760. |